Tim Jasper Knotnerus
Chief Executive Officer, AgomAb Therapeutics NV.
Companies
- AgomAb Therapeutics NVBoard member Mar 18, 2026 to now1
- AgomAb Therapeutics NVChief executive officer Mar 18, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- AgomAb Therapeutics NV AGMB45,217 shares2$382.1K at $8.45Mar 18, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAgomAb Therapeutics NV, Board member
- 2